Business Context and Reporting Period
This Form 8-K is a current report filed by OncoGenex Pharmaceuticals, Inc. (noted as "ACHIEVE LIFE SCIENCES, INC." in metadata) on May 9, 2011. The filing serves to announce the company's financial results for the first quarter of 2011 via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
The filing does not provide specific data regarding material changes versus the prior comparable period. It solely references the issuance of the Q1 2011 results announcement.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, or contingencies. It notes that the information in Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Verify the specific Q1 2011 financial figures (revenue, net loss, cash position) in the attached Exhibit 99.1 press release.
- Confirm the company's current legal name, as the metadata lists "ACHIEVE LIFE SCIENCES, INC." while the filing header lists "ONCOGENEX PHARMACEUTICALS, INC."
- Review the full press release for any operational updates or pipeline developments not summarized in this 8-K.